All Stories

  1. Preliminary Study on PCC-Chitosan’s Ability to Enhance Microplastic Excretion in Human Stools from Healthy Volunteers
  2. Enhanced Oil Binding Potential of Procambarus clarkii Chitosan (PCC): A Study with Extra Virgin Olive Oil and Sunflower Oil Under Simulated Gastric Conditions
  3. Plastic Smell: A Review of the Hidden Threat of Airborne Micro and Nanoplastics to Human Health and the Environment
  4. Genotoxic and neurotoxic potential of intracellular nanoplastics: A review
  5. Molecular Docking Analysis at the Human α7-nAChR and Proliferative and Evoked-Calcium Changes in SH-SY5Y Cells by Imidacloprid and Acetamiprid Insecticides
  6. Evaluation of the red blood cell distribution width-to-lymphocyte ratio (RLR) and red blood cell distribution width-to-platelet ratio (RPR) as predictors of COVID-19 in-hospital mortality
  7. Neurocytotoxicity of imidacloprid- and acetamiprid-based comercial insecticides over the differentiation of SH-SY5Y neuroblastoma cells
  8. Analysis of Socio-demographic, Economic and Individual Reasons for COVID-19 Vaccination Hesitancy in Ecuador: A Nationwide Longitudinal Study
  9. Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders
  10. Scientific pertinence of developing machine learning technologies for the triage of COVID-19 patients: A bibliometric analysis via Scopus
  11. Mean corpuscular haemoglobin concentration (MCHC): a new biomarker for high-altitude pulmonary edema in the Ecuadorian Andes
  12. Haematological indicators of mortality in people with community-acquired pneumonia living at high altitude
  13. Sex-Dependent Performance of the Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte and Mean Platelet Volume-to-Platelet Ratios in Discriminating COVID-19 Severity
  14. Biomarkers of severe COVID-19 pneumonia on admission using data-mining powered by common laboratory blood tests-datasets
  15. Does endogenous cholecystokinin modulate alcohol intake?
  16. Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A “Dimmer-Switch” Hypothesis
  17. Comparison between RT-qPCR for SARS-CoV-2 and expanded triage in sputum of symptomatic and asymptomatic COVID-19 subjects in Ecuador
  18. Common laboratory tests as indicators of COVID-19 severity on admission at high altitude: a single-center retrospective study in Quito (ECUADOR)
  19. Might a high hemoglobin mass be involved in non-cardiogenic pulmonary edema? The case of the chronic maladaptation to high-altitude in the Andes
  20. The Role of Brain Cyclooxygenase-2 (Cox-2) Beyond Neuroinflammation: Neuronal Homeostasis in Memory and Anxiety
  21. Overexpression of alpha-synuclein promotes both cell proliferation and cell toxicity in human SH-SY5Y neuroblastoma cells
  22. Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat
  23. Neurobiology of vitamin C: Expanding the focus from antioxidant to endogenous neuromodulator
  24. The unappreciated roles of the cholecystokinin receptor CCK(1) in brain functioning
  25. Interaction between cholecystokinin and the fibroblast growth factor system in the ventral tegmental area of selectively bred high- and low-responder rats
  26. Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons
  27. Striatal interaction among dopamine, glutamate and ascorbate
  28. Differential novelty detection in rats selectively bred for novelty-seeking behavior
  29. The CCK-system underpins novelty-seeking behavior in the rat: Gene expression and pharmacological analyses
  30. The CCK-system mediates adaptation to novelty-induced stress in the rat: A pharmacological evidence
  31. The 5-HT7 receptor: Role in novel object discrimination and relation to novelty-seeking behavior
  32. Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior
  33. Previous experience affects subsequent anxiety-like responses in rats bred for novelty seeking.
  34. The Potential Contributions of Chronic Inflammation to Lung Carcinogenesis
  35. Synthesis and Molecular Modeling of New 1-Aryl-3-[4-arylpiperazin-1-yl]-1-propane Derivatives with High Affinity at the Serotonin Transporter and at 5-HT1AReceptors
  36. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT1Areceptors
  37. 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-Based Potent and Selective CCK1Receptor Antagonists:  Structural Modifications at the Tryptophan Domain
  38. MDMA (`Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion
  39. 2-Oxopyrrolidines and 6-Oxoperhydropyrrolo[1,2-a]pyrazines as Templates in the Search for Nonpeptide Cholecystokinin Ligands.
  40. Synthesis and Stereochemical Structure−Activity Relationships of 1,3-Dioxoperhydropyrido[1,2-c]pyrimidine Derivatives:  Potent and Selective Cholecystokinin-A Receptor Antagonists
  41. Pharmacological evaluation of IQM-95,333, a highly selective CCKAreceptor antagonist with anxiolytic-like activity in animal models
  42. Pseudopeptide CCK-4 analogues incorporating the Ψ[CH(CN)NH] peptide bond surrogate
  43. CCK-4 restricted analogues containing a 3-oxoindolizidine skeleton